ConductScience.org, home

Paper3147154

Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.

Rossi F and 2 others. Clin Exp Immunol, 1988. Cited by 116 papers, by iCite.

Cite this record

ConductScience Library. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Papers, record 3147154. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3147154

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
3.86
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rossi FF
2Sultan YY
3Kazatchkine MDM D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, Anti-IdiotypicMajor topic
AntigensMajor topic
AutoantibodiesMajor topic
Factor VIIIMajor topic
Immunoglobulin IdiotypesMajor topic
IsoantibodiesMajor topic
Adult
Dose-Response Relationship, Immunologic
Female
Humans
Immunoglobulin Fab Fragments
Immunoglobulin G
Male
Middle Aged

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15070123The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs.Br J Haematol1972https://conductscience.org/library/papers/5070123PubMed
25070124The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs.Br J Haematol1972https://conductscience.org/library/papers/5070124PubMed
36792737A survey of 215 non-hemophilic patients with inhibitors to Factor VIII.Thromb Haemost1981https://conductscience.org/library/papers/6792737PubMed
46131213Altered distribution of T-lymphocyte subpopulations in children and adolescents with haemophilia.Lancet1983https://conductscience.org/library/papers/6131213PubMed
514284906ENZYMATIC DIGESTION OF RABBIT GAMMA GLOBULIN AND ANTIBODY AND CHROMATOGRAPHY OF DIGESTION PRODUCTS.Methods Med Res1964https://conductscience.org/library/papers/14284906PubMed
66148519Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.Lancet1984https://conductscience.org/library/papers/6148519PubMed
72857336Intravenous IgG for patients with spontaneous inhibitor to Factor VIII.Lancet1985https://conductscience.org/library/papers/2857336PubMed
83491036Antibody repertoires of normal BALB/c mice: B lymphocyte populations defined by state of activation.Immunol Rev1986https://conductscience.org/library/papers/3491036PubMed
93101065Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3101065PubMed
106378763Idiotypic networks and other preconceived ideas.Immunol Rev1984https://conductscience.org/library/papers/6378763PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
33523317Intravenous immunoglobulin as the rescue treatment in NMOSD patients.Neurol Sci2021https://conductscience.org/library/papers/33523317PubMed
30514798Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?Haematologica2019https://conductscience.org/library/papers/30514798PubMed
28967695Intravenous immunoglobulin for the treatment of childhood encephalitis.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28967695PubMed
26728503Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Haemophilia2016https://conductscience.org/library/papers/26728503PubMed
25504423Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.J Clin Immunol2015https://conductscience.org/library/papers/25504423PubMed
24200120Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies.J Peripher Nerv Syst2013https://conductscience.org/library/papers/24200120PubMed
20514213Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Curr Neuropharmacol2009https://conductscience.org/library/papers/20514213PubMed
19160072Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.Clin Rev Allergy Immunol2009https://conductscience.org/library/papers/19160072PubMed
17483070Intravenous immunoglobulin therapy for acquired coagulation inhibitors: a critical review.Int J Hematol2007https://conductscience.org/library/papers/17483070PubMed
17393290BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer.J Clin Immunol2007https://conductscience.org/library/papers/17393290PubMed
16391393Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.Clin Rev Allergy Immunol2005https://conductscience.org/library/papers/16391393PubMed
8617869Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.J Clin Invest1996https://conductscience.org/library/papers/8617869PubMed
8365019Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.Clin Exp Immunol1993https://conductscience.org/library/papers/8365019PubMed
8245176Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo.J Clin Immunol1993https://conductscience.org/library/papers/8245176PubMed
7593463In vitro synthesis of human IgE is suppressed by human IgG.J Clin Immunol1995https://conductscience.org/library/papers/7593463PubMed
7523452Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.J Clin Invest1994https://conductscience.org/library/papers/7523452PubMed
2312717
Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
J Clin Invest1990https://conductscience.org/library/papers/2312717PubMed
2122456Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2122456PubMed
2015703Beneficial effect of human therapeutic intravenous immunoglobulins (IVIg) in mercuric-chloride-induced autoimmune disease of Brown-Norway rats.Clin Exp Immunol1991https://conductscience.org/library/papers/2015703PubMed
1934588Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases.Clin Exp Immunol1991https://conductscience.org/library/papers/1934588PubMed

See all 21 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
COX8A1351PubTator's text mininghttps://conductscience.org/library/genes/1351NCBI Gene
FANCB2187PubTator's text mininghttps://conductscience.org/library/genes/2187NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3147154

GET https://conductscience.org/api/papers/v1/3147154/cited_by?page=2